Haemonetics Corporation (HAE) Overview
- 29 Mar 2026: Period ending 27 Jun 2026; Estimate (m); Actual 0.72; Beat / miss (m).
- 28 Sept 2025: Period ending 27 Dec 2025; Estimate (m); Actual 0.95; Beat / miss (m).
- 29 Jun 2025: Period ending 27 Sept 2025; Estimate (m); Actual 0.81; Beat / miss (m).
- 30 Mar 2025: Period ending 28 Jun 2025; Estimate (m); Actual 0.70; Beat / miss (m).
Stock Price Chart
View more →Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
- Last close
- $120.03
- Previous close
- $105.80
- Change
- $14.23
- Change (%)
- 13.45%
- Close date
- 2026-11-06
- Previous close date
- 2026-09-29
- Open
- (m)
- Day high
- (m)
- Day low
- (m)
- Last session volume
- (m)
- Last session value
- (m)
- Currency
- USD
- Price basis
- split-adjusted
- Volume basis
- (m)
Performance
View more →Cumulative total returns · 2026-09-29
YTD
- HAE
- +32.00%
- S&P 500
- (m)
1 year
- HAE
- +119.87%
- S&P 500
- (m)
3 years
- HAE
- +18.11%
- S&P 500
- (m)
5 years
- HAE
- +50.16%
- S&P 500
- (m)
Earnings trends
View more →Earnings per share
USD / share · As filed
27 Jun 2026 ○ Estimate (m) ● Actual 0.72
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 29 Mar 2026 | 27 Jun 2026 | (m) | 0.72 | (m) | (m) |
| 28 Sept 2025 | 27 Dec 2025 | (m) | 0.95 | (m) | (m) |
| 29 Jun 2025 | 27 Sept 2025 | (m) | 0.81 | (m) | (m) |
| 30 Mar 2025 | 28 Jun 2025 | (m) | 0.70 | (m) | (m) |
| 29 Sept 2024 | 28 Dec 2024 | (m) | 0.74 | (m) | (m) |
28 Mar 2026 ○ Estimate (m) ● Actual 2.05
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 30 Mar 2025 | 28 Mar 2026 | (m) | 2.05 | (m) | (m) |
| 31 Mar 2024 | 29 Mar 2025 | (m) | 3.31 | (m) | (m) |
| 2 Apr 2023 | 30 Mar 2024 | (m) | 2.29 | (m) | (m) |
| 3 Apr 2022 | 1 Apr 2023 | (m) | 2.24 | (m) | (m) |
| 4 Apr 2021 | 2 Apr 2022 | (m) | 0.84 | (m) | (m) |
(m)
Revenue vs. Earnings
USD
27 Jun 2026 ■ Revenue 339.38M ■ Earnings 33.01M — Profit margin 9.73%
28 Mar 2026 ■ Revenue 1.33B ■ Earnings 0.00B — Profit margin 0.01%
Analyst insights
View more →| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|---|---|---|---|---|---|---|---|---|
| (m) | (m) | (m) | (m) | (m) | $120.03 | (m) | (m) | (m) | (m) |
Recent news
View more →(m)
YouTube videos mentioning HAE
View more →(m)
Statistics
View more →Retained observations as of 2026-11-11; financial period ending 27 Jun 2026.
- Forward P/E
- (m)
- PEG ratio · 5-year expected
- (m)
- Shares held by insiders
- (m)
- Insider transactions · change (%)
- (m)
- Shares held by institutions
- (m)
- Institutional transactions · change (%)
- (m)
- Diluted EPS · 12 month
- (m)
- EPS estimate · next quarter
- (m)
- EPS estimate · next year
- (m)
- EPS growth · current annual estimate
- (m)
- EPS growth · next annual estimate
- (m)
- EPS growth · next 5 years expected
- (m)
- EPS growth · past 3 years annualized
- (m)
- EPS growth · past 5 years annualized
- (m)
- EPS change · 12 months vs prior year
- (m)
- EPS change · latest quarter vs previous quarter
- (m)
- Latest earnings report date
- (m)
- EPS surprise · latest reported quarter
- (m)
- Net income · 12 month
- $-923.69K
- Gross margin · 12 months
- 59.03%
- Profit margin
- -0.07%
- Return on assets · 12 month
- -0.04%
- Index membership
- (m)
- Employees
- (m)
- IPO date
- (m)
- Options available
- (m)
- Shortable
- (m)
- Analyst recommendation
- (m)
- Analyst target price
- (m)
- Price volatility · week
- (m)
- Price volatility · month
- (m)
- Average true range · 14 sessions
- (m)
- Relative strength index · 14 sessions
- (m)
- Relative volume
- (m)
- Average daily volume
- 588.69K
- Latest session volume
- (m)
- Last session value
- (m)
- 30 days ago session value
- (m)
- 1 year ago session value
- (m)
- Number of trades
- (m)
- Total return · week
- -2.51%*
- Total return · month
- 1.77%*
- Total return · quarter
- 40.84%*
- Total return · half year
- 95.78%*
- Total return · year to date
- 32.00%*
- Total return · 1 year
- 119.87%*
- Total return · 3 years
- 18.11%*
- Total return · 5 years
- 50.16%*
- Market cap
- (m)
- Book value per share · latest quarter
- (m)
- Price / cash · latest quarter
- (m)
- Enterprise value
- (m)
- Enterprise value / revenue
- (m)
- Enterprise value / EBITDA
- (m)
- Dividend · 12 months per share
- (m)
- Dividend ex-date
- (m)
- Next dividend ex-date
- (m)
- Next dividend amount per share
- (m)
- Dividend growth · 3 years annualized
- (m)
- Dividend growth · 5 years annualized
- (m)
- Revenue · 12 month
- $1.35B
- Revenue growth · past 3 years annualized
- (m)
- Revenue growth · past 5 years annualized
- (m)
- Revenue change · 12 months vs prior year
- (m)
- Revenue change · latest quarter vs previous quarter
- (m)
- Revenue surprise · latest reported quarter
- (m)
- Operating cash flow · 12 months
- $328.15M
- Free cash flow · 12 months (USD)
- $291.22M
- Levered free cash flow · 12 month
- (m)
- Debt / equity · latest quarter
- (m)
- Long-term debt / equity · latest quarter
- 140.26%*
- Return on equity · 12 month
- (m)
- Return on invested capital · 12 months
- (m)
- Previous close
- (m)
- Latest closing price
- (m)
- Latest session change (%)
- (m)
- 52-week high
- (m)
- 52-week low
- (m)
- Price vs 20-session moving average
- (m)
- Price vs 50-session moving average
- (m)
- Price vs 200-session moving average
- (m)
- Float shares
- (m)
- Short float (%)
- (m)
- Short ratio (days to cover)
- (m)
- Short interest (shares)
- (m)
Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.
Holders breakdown
View more →| Breakdown | Ownership |
|---|---|
| (m) | Shares held by all insiders |
| (m) | Shares held by institutions |
| (m) | Float held by institutions |
| (m) | Institutions holding shares |
Other holders
(m)
Insider holders
(m)
Top institutional holders
(m)
Top mutual fund holders
(m)
Haemonetics Corporation Overview
View more →(m)
(m)
- SEC CIK
- 313143
- Industry (SIC)
- 3841 Surgical & Medical Instruments & Apparatus
- Country of operation
- United States
- Business address
- 125 SUMMER STREET, BOSTON, Massachusetts, 02110, United States
- Fiscal year end
- 0403
- Phone
- 7818487100
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |